Geneva Partners, LLC Danaher Corp Transaction History

Geneva Partners, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$257.27 - $315.76 $257,269 - $315,760	-1,000 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$292.08 - $329.01 $292,080 - $329,010	1,000 New	1,000 $329,000
Q1 2021 May 05, 2021	SELL	$212.38 - $245.9 $546,878 - $633,192	-2,575 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$212.5 - $245.46 $397,375 - $459,010	-1,870 Reduced 42.07%	2,575 $572,000
Q3 2020 Oct 28, 2020	SELL	$177.16 - $215.33 $28,345 - $34,452	-160 Reduced 3.47%	4,445 $957,000
Q2 2020 Jul 20, 2020	BUY	$128.7 - $176.83 $95,237 - $130,854	740 Added 19.15%	4,605 $814,000
Q1 2020 Apr 27, 2020	SELL	$121.39 - $169.05 $509,231 - $709,164	-4,195 Reduced 52.05%	3,865 $535,000
Q4 2019 Feb 04, 2020	BUY	$133.47 - $153.48 $20,020 - $23,022	150 Added 1.9%	8,060 $1.24 Million
Q3 2019 Nov 06, 2019	BUY	$135.4 - $146.47 $442,081 - $478,224	3,265 Added 70.29%	7,910 $1.14 Million
Q2 2019 Jul 31, 2019	SELL	$124.88 - $143.73 $62,440 - $71,865	-500 Reduced 9.72%	4,645 $664,000
Q1 2019 May 10, 2019	SELL	$97.62 - $132.29 $3,904 - $5,291	-40 Reduced 0.77%	5,145 $679,000
Q2 2018 Aug 09, 2018	SELL	$96.1 - $103.24 $2,883 - $3,097	-30 Reduced 0.58%	5,185 $512,000
Q1 2018 May 08, 2018	SELL	$92.16 - $103.8 $47,923 - $53,976	-520 Reduced 9.07%	5,215 $510,000
Q3 2017 Nov 08, 2017	BUY	$79.29 - $88.45 $454,728 - $507,260	5,735	5,735 $492,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.